Literature DB >> 16905172

Transient low pH treatment enhances infection of lentiviral vector pseudotypes with a targeting Sindbis envelope.

Kouki Morizono1, Gene-Errol Ringpis, Nonia Pariente, Yiming Xie, Irvin S Y Chen.   

Abstract

Efficient transduction of primary hematopoietic cell types by oncoretroviral vectors and lentiviral vectors with a variety of different envelope pseudotypes has proven to be difficult. We recently developed a lentiviral vector based upon a modified Sindbis virus envelope that allows targeted transduction via antibody recognition to specific cells in unfractionated cell populations. However, similar to other envelope pseudotypes, the utility of this vector for some primary hematopoietic cells was limited by low transduction efficiencies. Here, we report that transient treatment of cells with low pH culture medium immediately following infection results in marked enhancements in transduction efficiency for primary hematopoietic cells. In combination with antibody directed targeting, this simple technique expands the utility of targeting transduction to specific cells in mixed populations of primary cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16905172     DOI: 10.1016/j.virol.2006.07.015

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Targeted transduction via CD4 by a lentiviral vector uses a clathrin-mediated entry pathway.

Authors:  Min Liang; Kouki Morizono; Nonia Pariente; Masakazu Kamata; Benhur Lee; Irvin S Y Chen
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

2.  Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins.

Authors:  Kouki Morizono; Amy Ku; Yiming Xie; Airi Harui; Sam K P Kung; Michael D Roth; Benhur Lee; Irvin S Y Chen
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

3.  Role of phosphatidylserine receptors in enveloped virus infection.

Authors:  Kouki Morizono; Irvin S Y Chen
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

4.  Involvement of non-structural proteins (NS) in influenza A infection and viral tropism.

Authors:  Xinmin Yan; Qiuwei Wang; Zhiqing Zhang; Yiming Xie; Hong Zhang; Miriam Razi; Shen Hu; Lijun Zhang; Jinluo Cheng; Shen Pang
Journal:  Biochem Biophys Res Commun       Date:  2012-10-08       Impact factor: 3.575

5.  Antibody-directed lentiviral gene transduction in early immature hematopoietic progenitor cells.

Authors:  Xia Zhang; Monica J Roth
Journal:  J Gene Med       Date:  2010-12       Impact factor: 4.565

6.  Retargeting vesicular stomatitis virus glycoprotein pseudotyped lentiviral vectors with enhanced stability by in situ synthesized polymer shell.

Authors:  Min Liang; Ming Yan; Yunfeng Lu; Irvin S Y Chen
Journal:  Hum Gene Ther Methods       Date:  2013-02       Impact factor: 2.396

7.  Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter.

Authors:  Lai Sum Leoh; Kouki Morizono; Kathleen M Kershaw; Irvin S Y Chen; Manuel L Penichet; Tracy R Daniels-Wells
Journal:  J Gene Med       Date:  2014 Jan-Feb       Impact factor: 4.565

8.  A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.

Authors:  Kouki Morizono; Yiming Xie; Gustavo Helguera; Tracy R Daniels; Timothy F Lane; Manuel L Penichet; Irvin S Y Chen
Journal:  J Gene Med       Date:  2009-08       Impact factor: 4.565

9.  Redirecting lentiviral vectors by insertion of integrin-tageting peptides into envelope proteins.

Authors:  Kouki Morizono; Nonia Pariente; Yiming Xie; Irvin S Y Chen
Journal:  J Gene Med       Date:  2009-07       Impact factor: 4.565

10.  Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus.

Authors:  Xian-Yang Zhang; Robert H Kutner; Agnieszka Bialkowska; Michael P Marino; William B Klimstra; Jakob Reiser
Journal:  Retrovirology       Date:  2010-01-25       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.